XBiotech XBIT Stock
9.25 USD
{{ price }}
-2.631579%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
281.67M USD
LOW - HIGH [24H]
9.09
-
9.52 USD
VOLUME [24H]
53.87K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.81 USD
XBiotech Price Chart
XBiotech XBIT Financial and Trading Overview
| XBiotech stock price | 9.25 USD |
| Previous Close | 6.38 USD |
| Open | 6.48 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 900 |
| Day's Range | 6.08 - 6.48 USD |
| 52 Week Range | 3 - 6.69 USD |
| Volume | 44.85K USD |
| Avg. Volume | 88.86K USD |
| Market Cap | 186.9M USD |
| Beta (5Y Monthly) | 1.202112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 15, 2021 |
| 1y Target Est | N/A |
XBIT Valuation Measures
| Enterprise Value | -25764852 USD |
| Trailing P/E | N/A |
| Forward P/E | 47.23077 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 53.247093 |
| Price/Book (mrq) | 0.7888989 |
| Enterprise Value/Revenue | -7.34 |
| Enterprise Value/EBITDA | 0.819 |
Trading Information
XBiotech Stock Price History
| Beta (5Y Monthly) | 1.202112 |
| 52-Week Change | 19.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.69 USD |
| 52 Week Low | 3 USD |
| 50-Day Moving Average | 4.26 USD |
| 200-Day Moving Average | 3.78 USD |
XBIT Share Statistics
| Avg. Volume (3 month) | 88.86K USD |
| Avg. Daily Volume (10-Days) | 93.77K USD |
| Shares Outstanding | 30.44M |
| Float | 19.8M |
| Short Ratio | 0.51 |
| % Held by Insiders | 36.86% |
| % Held by Institutions | 13.01% |
| Shares Short | 86.93K |
| Short % of Float | 0.50% |
| Short % of Shares Outstanding | 0.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -962.67% |
| Gross Margin | 87.52% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -8.23% |
| Return on Equity (ttm) | -12.46% |
Income Statement
| Revenue (ttm) | 3.51M USD |
| Revenue Per Share (ttm) | 0.12 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 3.36M USD |
| EBITDA | -31443000 USD |
| Net Income Avi to Common (ttm) | -31321000 USD |
| Diluted EPS (ttm) | -1.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 212.66M USD |
| Total Cash Per Share (mrq) | 6.99 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 59.78 |
| Book Value Per Share (mrq) | 7.783 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14509000 USD |
| Levered Free Cash Flow (ttm) | -6618750 USD |
Profile of XBiotech
| Country | United States |
| State | TX |
| City | Austin |
| Address | 5217 Winnebago Lane |
| ZIP | 78744 |
| Phone | 512 386 2900 |
| Website | https://www.xbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 84 |
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Q&A For XBiotech Stock
What is a current XBIT stock price?
XBiotech XBIT stock price today per share is 9.25 USD.
How to purchase XBiotech stock?
You can buy XBIT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for XBiotech?
The stock symbol or ticker of XBiotech is XBIT.
Which industry does the XBiotech company belong to?
The XBiotech industry is Biotechnology.
How many shares does XBiotech have in circulation?
The max supply of XBiotech shares is 30.45M.
What is XBiotech Price to Earnings Ratio (PE Ratio)?
XBiotech PE Ratio is now.
What was XBiotech earnings per share over the trailing 12 months (TTM)?
XBiotech EPS is -0.81 USD over the trailing 12 months.
Which sector does the XBiotech company belong to?
The XBiotech sector is Healthcare.
XBiotech XBIT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}